These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22018773

  • 21. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [Abstract] [Full Text] [Related]

  • 22. [Clozapine-induced agranulocytosis].
    Valevski A, Modai I, Weizman A.
    Harefuah; 1994 Jan 02; 126(1):32-5. PubMed ID: 7511125
    [No Abstract] [Full Text] [Related]

  • 23. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb 02; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

  • 24. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA, Lindenmayer JP.
    J Clin Psychopharmacol; 2007 Dec 02; 27(6):714-5. PubMed ID: 18004146
    [No Abstract] [Full Text] [Related]

  • 25. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA, Faber HJ, Hordijk P, Uges DR, Smit A.
    Neth J Med; 1998 Jan 02; 52(1):26-9. PubMed ID: 9573739
    [Abstract] [Full Text] [Related]

  • 26. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
    Ruiz-Doblado S, Plasencia-García de Diego B, Perea-Pérez R, Jiménez-Gonzalo F.
    Actas Esp Psiquiatr; 2020 Mar 02; 48(2):89-91. PubMed ID: 32463914
    [No Abstract] [Full Text] [Related]

  • 27. Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis.
    Gerson SL, Gullion G, Yeh HS, Masor C.
    Lancet; 1992 Oct 31; 340(8827):1097. PubMed ID: 1383662
    [No Abstract] [Full Text] [Related]

  • 28. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J, Berdichevsky E, Conte G, Tellez C.
    Rev Med Chil; 1994 Jun 31; 122(6):694-8. PubMed ID: 7732216
    [Abstract] [Full Text] [Related]

  • 29. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
    Lally J, Malik S, Whiskey E, Taylor DM, Gaughran FP, Krivoy A, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Aug 31; 37(4):441-446. PubMed ID: 28437295
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic dilemmas in treatment-resistant bipolar patients.
    Bota RG, Sagduyu K.
    South Med J; 2008 Jun 31; 101(6):584. PubMed ID: 18475231
    [No Abstract] [Full Text] [Related]

  • 31. Thrombocytosis due to clozapine treatment: working towards an early marker for clozapine-induced agranulocytosis.
    Marlowe K.
    Br J Psychiatry; 2000 Oct 31; 177():372-3. PubMed ID: 11116788
    [No Abstract] [Full Text] [Related]

  • 32. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
    Loeffler S, Fehsel K, Henning U, Fischer J, Agelink M, Kolb-Bachofen V, Klimke A.
    Pharmacopsychiatry; 2003 Jan 31; 36(1):37-41. PubMed ID: 12649775
    [Abstract] [Full Text] [Related]

  • 33. Clozapine-induced agranulocytosis treated with granulocyte macrophage colony stimulating factor.
    Oren R, Granat E, Shtrussberg S, Matzner Y.
    Br J Psychiatry; 1993 May 31; 162():686-7. PubMed ID: 8149123
    [Abstract] [Full Text] [Related]

  • 34. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
    Comacchio C, Dusi N, Lasalvia A.
    J Clin Psychopharmacol; 2016 Apr 31; 36(2):173-4. PubMed ID: 26859277
    [No Abstract] [Full Text] [Related]

  • 35. Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
    Oh EJ, Chae HJ, Park YJ, Park JW, Han K.
    Am J Hematol; 2007 Jun 31; 82(6):500. PubMed ID: 17266051
    [No Abstract] [Full Text] [Related]

  • 36. Clozapine: the commitment to patient safety.
    Alphs LD, Anand R.
    J Clin Psychiatry; 1999 Jun 31; 60 Suppl 12():39-42. PubMed ID: 10372610
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of clozapine-induced agranulocytosis using granulocyte colony-stimulating factor].
    Gruner U, tho Pesch S, Spittler S, Schaefer HE, Peters U.
    Dtsch Med Wochenschr; 1994 Oct 28; 119(43):1467-70. PubMed ID: 7525175
    [Abstract] [Full Text] [Related]

  • 38. Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF).
    Weide R, Köppler H, Heymanns J, Pflüger KH, Havemann K.
    Br J Haematol; 1992 Apr 28; 80(4):557-9. PubMed ID: 1374635
    [No Abstract] [Full Text] [Related]

  • 39. Re: Cytokines and agranulocytosis induced by clozapine.
    Malek-Ahmadi P.
    Can J Psychiatry; 1996 Nov 28; 41(9):603. PubMed ID: 8946085
    [No Abstract] [Full Text] [Related]

  • 40. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.
    J Clin Psychiatry; 2006 Oct 28; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.